6.22 A Double-Blind, Placebo-Controlled, Dose-Ranging Study of Extended-Release Viloxazine (SPN-812 ER) in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

2017 ◽  
Vol 56 (10) ◽  
pp. S283-S284
Author(s):  
Janet K. Johnson ◽  
Keith Saylor ◽  
Scott T. Brittain ◽  
Gabriela Tulloch ◽  
Tesfaye Liranso
Sign in / Sign up

Export Citation Format

Share Document